A GLP-1 telehealth provider
GLP-1
Physician-supervised semaglutide and tirzepatide with transparent monthly pricing.
- Best for
- Fastest access to branded or compounded GLP-1s
- Rating
- 4.6
- From
- $—/mo
Independent research desk · est. 2026
Aminoscope is an independent research desk reviewing peptides, GLP-1 medications, and longevity therapeutics — every claim traced to primary literature.
Every figure traced to the trial, the FDA label, or the paper of record — live-verified before it publishes.
BPC-157, TB-500, GHK-Cu, sermorelin, ipamorelin and the broader therapeutic-peptide landscape — what the evidence actually shows.
Explore →glp 1Semaglutide, tirzepatide, and the incretin pipeline — efficacy, safety, access, and cost, read straight from the trials.
Explore →longevityNAD⁺, senolytics, mitochondrial peptides, and healthspan interventions — separating durable signal from hype.
Explore →We cite the trial, the FDA label, or the peer-reviewed paper — never a secondary summary.
Every reference is checked against the source of record before publication, not pulled from memory.
We rank on evidence. Where partnerships exist, they are labeled and never move the verdict.
We rank providers on evidence and transparency. Commercial relationships set the order of partners — never the verdict.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
GLP-1
Physician-supervised semaglutide and tirzepatide with transparent monthly pricing.
Peptides
Lab-tested peptide protocols with clinician oversight and third-party COAs.
Longevity
Biomarker-led healthspan programs spanning NAD⁺, peptides, and metabolic care.